Spinillo A, Tenti P, Rao S, Zappatore R, Romagnoli S, Pizzoli G
Istituti di Clinica Ostetrica e Ginecologica and Anatomia Patologica, Università di Pavia, Policlinico S. Matteo, Italy.
Am J Obstet Gynecol. 1994 Sep;171(3):773-7. doi: 10.1016/0002-9378(94)90096-5.
Our purpose was to evaluate the proliferative activity of cervical intraepithelial neoplasia lesions in human immunodeficiency virus-seropositive women.
The proliferative activity of cervical intraepithelial neoplasia lesions was measured by nucleolar organizer regions-associated proteins count. Twenty-two biopsy specimens of cervical intraepithelial neoplasia lesions from patients positive for human immunodeficiency virus were compared with 22 matched biopsy specimens obtained from controls negative for the virus.
The mean count of nucleolar organizer regions-associated proteins per cell was 9.5 +/- 3.7 (SD) in human immunodeficiency virus-positive patients and 7.6 +/- 2.8 in human immunodeficiency virus-negative controls (p < 0.0001 by Poisson test of heterogeneity of counts). The difference in counts between the two groups, which was confirmed by log-linear analysis, persisted within each severity stratum of cervical intraepithelial neoplasia and was independent of associated human papillomavirus infection. In human immunodeficiency virus-positive patients log-linear analysis showed that high-grade cervical intraepithelial neoplasia, the presence of human papillomavirus infection, and the severity of human immunodeficiency virus disease were independently correlated with increased nucleolar organizer regions-associated protein counts per cell.
The results of this study indicate that the proliferative activity of cervical intraepithelial neoplasia lesions of human immunodeficiency virus-positive patients was increased compared with matched lesions from human immunodeficiency virus-negative women. This finding suggests the possibility of an increased oncogenic progression of cervical intraepithelial neoplasia lesions in human immunodeficiency virus-positive patients.
我们的目的是评估人类免疫缺陷病毒血清反应阳性女性宫颈上皮内瘤变病变的增殖活性。
通过核仁组织区相关蛋白计数来测量宫颈上皮内瘤变病变的增殖活性。将22例来自人类免疫缺陷病毒阳性患者的宫颈上皮内瘤变病变活检标本与22例来自病毒阴性对照的匹配活检标本进行比较。
人类免疫缺陷病毒阳性患者每细胞的核仁组织区相关蛋白平均计数为9.5±3.7(标准差),人类免疫缺陷病毒阴性对照为7.6±2.8(通过计数异质性的泊松检验,p<0.0001)。两组之间的计数差异经对数线性分析得到证实,在宫颈上皮内瘤变的每个严重程度分层中均持续存在,且与相关的人乳头瘤病毒感染无关。在人类免疫缺陷病毒阳性患者中,对数线性分析显示高级别宫颈上皮内瘤变、人乳头瘤病毒感染的存在以及人类免疫缺陷病毒疾病的严重程度与每细胞核仁组织区相关蛋白计数增加独立相关。
本研究结果表明,与人类免疫缺陷病毒阴性女性的匹配病变相比,人类免疫缺陷病毒阳性患者宫颈上皮内瘤变病变的增殖活性增加。这一发现提示人类免疫缺陷病毒阳性患者宫颈上皮内瘤变病变致癌进展增加的可能性。